journal article·2025-07-29Open access

Correlations Between the Opioid System, Imidazoline Receptors, and EEG: An Investigation of Acquired Drug-Seeking Behaviors in Different Environments

Gabriela Rusu-Zota, Dan Trofin, Cristina Gales, Elena Porumb-Andrese

Applied Sciences· Volume 15· Issue 15

Abstract

The investigation of the reward system is a fascinating domain with future applications for pain therapy and understanding addiction. We investigated interactions between tramadol use and the imidazoline system, through the modulatory effects of imidazoline receptor blockers, by behavior analysis and electroencephalography (EEG). Thirty-six male Wistar rats were placed within a conditioned place preference (CCP) setting using a three-compartment box apparatus. The transition of the six groups of subjects from one compartment to another was constantly monitored, related to preconditioning for one day, conditioning for eight days, and post-conditioning testing on day 10. During the conditioning phase, the groups received: a saline solution, efaroxan, idazoxan, tramadol, tramadol + efaroxan, and tramadol + idazoxan, respectively. The administration of efaroxan, idazoxan, or a saline solution in the non-preferred compartment did not alter the time spent by rats there. On the other hand, the administration of tramadol alone in the non-preferred compartment significantly increased the time spent by animals there (151.66 ± 11.69 s) post-conditioning as compared to preconditioning (34.5 ± 5.31 s) (p < 0.01), while the combination of efaroxan and tramadol significantly reduced its effect. After the combination with idazoxan, the effect of tramadol on increasing the time spent by the animal in the non-preferred compartment remained significantly higher than in the preconditioning phase. A significant increase in time spent in the non-preferred compartment demonstrates the existence of a CPP induction effect (by changing the preference). The effects of tramadol on the reward system can cause changes in the brain’s neuroplasticity, potentially leading to learned behaviors that promote drug seeking in previous non-preferred environments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Veterinary Pharmacology and Anesthesia · Neurotransmitter Receptor Influence on Behavior · Pharmacological Effects and Assays

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, Clinical Pharmacology and Algesiology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania

Department of Biomedical Sciences, Faculty of Medical Bioengineering, University of Medicine and Pharmacy “Grigore T. Popa”, 700454 Iasi, Romania

Department of Histology, “Grigore T. Popa” University of Medicine and Pharmacy, Universitatii Street 16, 700115 Iasi, Romania

Department of Medical Specialties (III)—Disciplines of Dermatology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania

References (68)

Show source-provided references
1. Imidazoline Receptor System: The Past, the Present, and the Future10.1124/pr.118.016311 ↗
2. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer’s disease10.1111/bph.15312 ↗
3. Agmatine and imidazoline receptors: Their role in opioid analgesia, tolerance and dependence10.1007/s10571-007-9164-y ↗
4. Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery10.12659/MSM.894066 ↗
5. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic10.1016/S0022-3565(25)11227-5 ↗
6. An overview of tramadol and its usage in pain management and future perspective10.1016/j.biopha.2018.12.085 ↗
7. Pharmacology of tramadol10.2165/00003495-199700532-00006 ↗
8. Tramadol and acetaminophen combination for chronic non-cancer pain10.1517/14656566.2013.839985 ↗
9. Synergism between gabapentin-tramadol in experimental diabetic neuropathic pain10.1111/fcp.12400 ↗
10. Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats10.1016/j.lfs.2005.06.024 ↗
11. Yang, C., Li, W.Y., Yu, H.Y., Gao, Z.Q., Liu, X.L., Zhou, Z.Q., and Yang, J.J. (2012). Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex. J. Biomed. Biotechnol., 2012.10.1155/2012/175619 ↗
12. μ-Opioid receptor-dependent and independent components in effects of tramadol10.1016/j.neuropharm.2006.05.008 ↗
13. Amelioration of the reduced antinociceptive effect of morphine in the unpredictable chronic mild stress model mice by noradrenalin but not serotonin reuptake inhibitors10.1186/s12990-015-0051-0 ↗
14. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors10.1016/j.tins.2007.03.003 ↗
15. The reward circuit: Linking primate anatomy and human imaging10.1038/npp.2009.129 ↗
16. Trends in Tramadol: Pharmacology, Metabolism, and Misuse10.1213/ANE.0000000000001683 ↗
17. Mechanistic and functional differentiation of tapentadol and tramadol10.1517/14656566.2012.696097 ↗
18. Clinical pharmacology of tramadol10.2165/00003088-200443130-00004 ↗
19. Ketoprofen and tramadol pharmacokinetics in patients with chronic pancreatitis
20. Acute tramadol enhances brain activity associated with reward anticipation in the nucleus accumbens10.1007/s00213-018-4955-z ↗
21. Dependence potential of tramadol: Behavioral pharmacology in rodents10.4062/biomolther.2014.064 ↗
22. Tramadol induces conditioned place preference in rats: Interactions with morphine and buprenorphine10.1016/j.neulet.2012.05.037 ↗
23. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade10.1111/j.1369-1600.2007.00070.x ↗
24. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol10.1002/syn.10025 ↗
25. Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol10.1016/S0304-3940(02)00571-2 ↗
26. Electroencephalography for diagnosis and prognosis of acute encephalitis10.1016/j.clinph.2014.11.006 ↗
27. The relationship between epileptiform discharges and background activity in the visual analysis of electroencephalographic examinations in dogs with seizures of different etiologies10.1016/j.tvjl.2017.03.003 ↗
28. Gender Differences in the Reinforcing Properties of Morphine10.1016/S0091-3057(99)00174-4 ↗
29. Sex Differences in Morphine Analgesia: An Experimental Study in Healthy Volunteers10.1097/00000542-200011000-00018 ↗
30. Male sexual behaviour: Further studies on the role of alpha 2-adrenoceptors10.1006/phrs.1993.1107 ↗
31. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine10.1111/j.1476-5381.1996.tb15150.x ↗
32. Acute and chronic tramadol administration impair spatial memory in rat
33. Effects of chronic tramadol administration on cognitive flexibility in mice10.1007/s00213-021-05903-x ↗
34. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain10.1213/ANE.0b013e31825683c3 ↗
35. Melatonin attenuates morphine-induced conditioned place preference in Wistar rats10.1002/brb3.2397 ↗
36. Simvastatin Blocks Reinstatement of Cocaine-induced Conditioned Place Preference in Male Mice with Brain Lipidome Remodeling10.1007/s12264-021-00771-z ↗
37. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
38. What is the main mechanism of tramadol?10.1007/s00210-015-1167-5 ↗
39. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with μ opioid agonists in rhesus monkeys10.1007/s002130050490 ↗
40. French Network of Centre for Evaluation and Information on Pharmacodependence (Addictovigilance Centres) Evaluation of abuse and dependence in addiction monitoring systems: Tramadol as an example10.2515/therapie/2014221 ↗
41. Identification of abuse and dependence cases through a hospital database10.1002/pds.3369 ↗
42. Nalbuphine could decrease the rewarding effect induced by tramadol in mice while enhancing its antinociceptive activity10.1016/j.ejphar.2015.03.062 ↗
43. Baik, J.H. (2013). Dopamine signaling in reward-related behaviors. Front. Neural Circuits, 7.10.3389/fncir.2013.00152 ↗
44. Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons10.1111/j.1471-4159.2008.05597.x ↗
45. NMDA receptors in the midbrain play a critical role in dopamine-mediated hippocampal synaptic potentiation caused by morphine10.1111/adb.12010 ↗
46. The competitive NMDA receptor antagonist CPP disrupts cocaine-induced conditioned place preference but spares behavioral sensitization10.1016/j.bbr.2012.10.042 ↗
47. Li, S., Zhang, X.Q., Liu, C.C., Wang, Z.Y., Lu, G.Y., Shen, H.W., Wu, N., Li, J., and Li, F. (2022). IRAS/Nischarin modulates morphine reward by glutamate receptor activation in the nucleus accumbens of mouse brain. Biomed. Pharmacother., 153.10.1016/j.biopha.2022.113346 ↗
48. Morphine-induced conditioned place preference in rhesus monkeys: Resistance to inactivation of insula and extinction10.1016/j.nlm.2016.04.005 ↗
49. Evidence for the involvement of glutamatergic and neuro-kinin 1 receptors in the antinociception elicited by tramadol in mice10.1159/000265551 ↗
50. Olson, K., Duron, D., Womer, D., Fell, R., and Streicher, J. (2019). Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids. PLoS ONE, 14.10.1371/journal.pone.0217371 ↗
51. Xia, W., Liu, G., Shao, Z., Xu, E., Yuan, H., Liu, J., and Gao, L. (2020). Toxicology of tramadol following chronic exposure based on metabolomics of the cerebrum in mice. Sci. Rep., 10.10.1038/s41598-020-67974-8 ↗
52. Tramadol-induced seizurogenic effect: A possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway10.1111/j.1742-7843.2008.00276.x ↗
53. Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its m1 metabolite in the rat kindling model of epilepsy10.1038/sj.bjp.0703562 ↗
54. Moxonidine for tramadol withdrawal symptoms during detoxification10.1136/bcr-2015-210444 ↗
55. The i1-imidazoline receptor in pc12 pheochromocytoma cells activates protein kinases c, extracellular signal-regulated kinase (erk) and c-jun n-terminal kinase (jnk)10.1046/j.1471-4159.2001.00632.x ↗
56. Presynaptic i1-imidazoline receptors reduce gabaergic synaptic transmission in striatal medium spiny neurons10.1523/JNEUROSCI.4642-05.2006 ↗
57. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: Evidence for the involvement of imidazoline I1 receptors10.1097/ALN.0b013e318164ca81 ↗
58. Agmatine inhibits behavioral sensitization to ethanol through imidazoline receptors10.1111/acer.13972 ↗
59. Neurophysiological Biomarkers of Parkinson’s Disease10.3233/JPD-191844 ↗
60. Brain-Computer Interface and Electrochemical Sensor Based on Boron-Nitrogen Co-Doped Graphene-Diamond Microelectrode for EEG and Dopamine Detection10.1021/acssensors.4c02461 ↗
61. Effects of chlorpromazine and some of its metabolites on the EEG and on dopamine metabolism of the isolated perfused rat brain10.1016/0014-2999(79)90267-X ↗
62. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics10.1016/bs.irn.2016.06.005 ↗
63. A systematic review on the role of EEG and fMRI-Neurofeedback training in the treatment of substance use disorders and behavioral addiction10.1016/j.psychres.2025.116474 ↗
64. Barbosa, J., Leal, S., Pereira, F., Dinis-Oliveira, R., and Faria, J. (2023). Tramadol and tapentadol induce conditioned place preference with a differential impact on rewarding memory and incubation of craving. Pharmaceuticals, 16.10.3390/ph16010086 ↗
65. The imidazoline receptors and ligands in pain modulation10.4103/0253-7613.165196 ↗
66. Lagard, C., Vodovar, D., Chevillard, L., Callebert, J., Caillé, F., Pottier, G., Liang, H., Risède, P., Tournier, N., and Mégarbane, B. (2022). Investigation of the Mechanisms of Tramadol-Induced Seizures in Overdose in the Rat. Pharmaceuticals, 15.10.3390/ph15101254 ↗
67. The influence of tramadol on bowel function: A randomised, placebo-controlled trial10.1111/bcpt.14067 ↗
68. Tramadol-induced mood elevation in a patient with no previous psychiatric history